Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

14.45 +0.88 (+6.48%)
Streaming Delayed Price Updated: 11:32 AM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Accolade Inc

< Previous 1 2 3 4 Next >
Analyst Expectations for Accolade's Future
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
 
Via Benzinga
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2023
 
Via Benzinga
Why Shares of Accolade Soared This Week
Strong revenue growth and encouraging guidance pushed the stock up. 
Via The Motley Fool
Analyst Initiates Coverage On Accolade, Says 'Differentiated In Growing Market'
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023
 
Via Benzinga
Analysts Stay Bullish On Accolade Stock, Call Q3 Earnings Better Than Expected Amid Challenging Backdrop
 
Via Benzinga
Accolade Analyst Finds Stock Attractively Valued Post Q3 Beat, T-5 Contract Win
 
Via Benzinga
Accolade's Return On Capital Employed Overview
 
Via Benzinga
Accolade Earnings Preview
 
Via Benzinga
Accolade Posts Narrower Quarterly Loss, Tightens Annual Sales Guidance
 
Via Benzinga
Analyst Ratings for Accolade
Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Analyst Ratings for Accolade
Accolade (NASDAQ:ACCD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Accolade Announces Results for Fiscal Third Quarter 2023
From Accolade, Inc.
Via Globe NewsWire
Earnings Scheduled For January 9, 2023
Companies Reporting Before The Bell • Commercial Metals (NYSE:CMC) is likely to report quarterly earnings at $1.96 per share on revenue of $2.20 billion. 
Via Benzinga
AMC Preferred Equity Units, Accolade And Some Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Accolade Announces Results for Fiscal Second Quarter 2023
From Accolade, Inc.
Via Globe NewsWire
Earnings Scheduled For October 6, 2022
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.52 per share on revenue of $2.85 billion. 
Via Benzinga
Accolade Earnings Preview
Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-10-06. Here's what investors need to know before the announcement. Analysts estimate that Accolade will... 
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. 
Via Benzinga
Delta Air Lines To Rally Around 84%? Here Are 5 Other Price Target Changes For Tuesday
Raymond James raised Delta Air Lines, Inc. (NYSE: DAL) price target from $50 to $52. Raymond James analyst Savanthi Syth maintained a Strong Buy rating on the stock. Delta Air shares rose 0.7% to close... 
Via Benzinga
Alphabet To $114? Plus This Analyst Predicts $145 For Disney
B of A Securities cut Alphabet Inc. (NASDAQ: GOOGL) price target from $125 to $114. Alphabet shares rose 1.9% to $100.50 in pre-market trading. 
Via Benzinga
Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here
Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
  
Via Benzinga
Where Accolade Stands With Analysts
  Over the past 3 months, 5 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Priority Health announces launch of new health navigation solution, PriorityGPS™
From Priority Health
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.